Go Pro
NASDAQ:ICLR

Icon Q3 2026 Earnings Report

Icon logo
$169.99 -0.36 (-0.21%)
Closing price 09/30/2026 04:00 PM Eastern
Extended Trading
$169.99 0.00 (0.00%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Icon EPS Results

Actual EPS
N/A
Consensus EPS
$2.66
Beat/Miss
N/A
One Year Ago EPS
N/A

Icon Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.01 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Icon Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call Date
Wednesday, October 21, 2026
Conference Call Time
4:00PM ET

Conference Call Resources

Icon Earnings Headlines

Insider Selling: Icon (NASDAQ:ICLR) Director Sells $569,625.00 in Stock
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
Icon (NASDAQ:ICLR) Director Sells $875,875.00 in Stock
See More Icon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Icon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Icon and other key companies, straight to your email.

About Icon

Icon (NASDAQ:ICLR) is a global contract research and clinical development organization headquartered in Dublin, Ireland. The company provides outsourced services to pharmaceutical, biotechnology, medical device and government organizations, supporting the development and commercialization of healthcare products.

Its services span clinical trial management, clinical and regulatory consulting, data management, biostatistics, medical writing, pharmacovigilance, laboratory services, medical imaging and commercialization support. ICON works across a range of therapeutic areas and helps sponsors design, manage and analyze clinical studies in accordance with regulatory requirements.

Founded in 1990, ICON has expanded from its origins in Ireland into an international organization serving customers across North America, Europe, Asia-Pacific and other global markets. The company significantly broadened its scale and capabilities through its acquisition of PRA Health Sciences, completed in 2021. ICON is led by Chief Executive Officer Steve Cutler.

View Icon Profile